P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG‐TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML‐001 TRIAL... von Wei, A. H., Döhner, H., Sayar, H., Ravandi, F., Montesinos, P., Dombret, H., Selleslag, D., Porkka, K., Jang, J.‐H., Skikne, B., Beach, C., Prebet, T., Zhang, G., Risueño, A., Ugidos Guerrero, M., See, W. L., Menezes, D., Roboz, G. J.

Volltext

Impact of Genomic Landscape and Mutational Burden on Primary Endpoint Responses in the COMMANDS Study von Komrokji, Rami S., Guerrero, Manuel Ugidos, Garcia-Manero, Guillermo, Zeidan, Amer M., Platzbecker, Uwe, Hayati, Sheida, Vodala, Sadanand

Volltext

Luspatercept Modulates Inflammation in the Bone Marrow, Restores Effective Erythropoiesis/Hematopoiesis, and Provides Sustained Clinical Benefit Versus Epoetin Alfa (EA): Biomarker... von Hayati, Sheida, Zeidan, Amer M., Garcia-Manero, Guillermo, Platzbecker, Uwe, Ahsan, Aarif, Verma, Amit K., Aluri, Srinivas, Guerrero, Manuel Ugidos, Gandhi, Anita K., Suragani, Rajasekhar N.V.S., Vodala, Sadanand

Volltext